Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT00660621 |
| Title | A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Glioma |
| Acronym | KARE004 |
| Recruitment | Unknown status |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Kentuckiana Cancer Institute, Eisai Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Kentuckiana Cancer Institute | RECRUITING | Louisville | Kentucky | 40202 | United States | Details |